In human lymphoma and colon carcinoma cells, AZD3965 inhibited both the import and export of monocarboxylates in cells, leading to elevated levels of bioenergy-related metabolites in both MCT4-positive and MCT4-negative cells [84]. This evidence concerns the gene SLC16A3 and lymphoma.